What are the potential impacts of Novarel administration on endometrial receptivity assays, and how does it influence implantation potential?
Gaurav ChauhanContributor
What are the potential impacts of Novarel on endometrial receptivity assays?
Share
Novarel, a hCG medication, can increase endometrial receptivity by promoting progesterone production, which enhances the chance of embryo implantation in assisted reproduction.
Novarel affects endometrial receptivity by supporting luteal phase changes, enhancing progesterone secretion essential for nurturing and allowing embryo implantation.
Novarel, containing hCG, can enhance endometrial receptivity by promoting secretion of nutrients and growth factors, potentially increasing implantation success rates.